UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008955 |
|---|---|
| Receipt number | R000010476 |
| Scientific Title | Randomized phase 2 study comparing maintenance treatments with paclitaxel plus bevacizumab and endocrine agent in patients with inoperable or recurrent breast cancer who received prior endocrine treatment and achieved non progressive disease during induction treatment with paclitaxel plus bevacizumab. |
| Date of disclosure of the study information | 2012/09/24 |
| Last modified on | 2019/05/17 16:00:32 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/09/21 11:54:47 | ||
| 2 | Update | 2013/11/13 09:08:46 | Public title Public title |
|
| 3 | Update | 2013/11/13 09:09:27 | Narrative objectives1 Narrative objectives1 |
|
| 4 | Update | 2013/11/13 09:17:42 | Key inclusion criteria Key inclusion criteria |
|
| 5 | Update | 2013/11/13 09:18:06 | Email |
|
| 6 | Update | 2017/11/15 07:44:34 | Name of primary person or sponsor Organization Email1 |
|
| 7 | Update | 2018/09/26 14:01:23 | Recruitment status |
|
| 8 | Update | 2019/03/28 12:54:15 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 9 | Update | 2019/05/17 15:55:57 | Email1 |
|
| 10 | Update | 2019/05/17 16:00:32 | Recruitment status Date of IRB Last follow-up date |
